Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edilmar Alvarado

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Scientific Reports|February 1, 2024
Impact of the COVID-19 pandemic on the incidence and type of infections in hospitalized patients with cirrhosis: a retrospective studyBerta Cuyàs, Anna Huerta, Maria Poca, et al.
Gastroenterologia Y Hepatologia|July 1, 2026
Anemia and Hypoalbuminemia are Associated with Hepatic Encephalopathy and Mortality after Portal Hypertension-Related BleedingLaura Bordoy, Anna Brujats, Montserrat Camps, et al.
Obesity Surgery|March 7, 2023
Bariatric Surgery Is Associated with Alcohol-Related Liver Disease and Psychiatric Disorders Associated with AUDEdilmar Alvarado-Tapias, David Marti-Aguado, Kevin Kennedy, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 18, 2024
Influence of further decompensation on survival across clinical stages of decompensated cirrhosis: The role of portal hypertension and HVPG changesMarta Garcia-Guix, Alba Ardevol, Victor Sapena, et al.
Plos One|March 25, 2016
Effects of an Exercise Programme on Functional Capacity, Body Composition and Risk of Falls in Patients with Cirrhosis: A Randomized Clinical TrialEva Román, Cristina García-Galcerán, Teresa Torrades, et al.
European Journal of Public Health|November 10, 2025
Trends in incidence, prevalence, and survival of primary liver cancer in the United Kingdom (2000-2021)Berta Cuyàs, Edilmar Alvarado-Tapias, Eng Hooi Tan, et al.
World Journal of Hepatology|February 6, 2018
Toll-like receptor 4 polymorphisms and bacterial infections in patients with cirrhosis and ascitesEdilmar Alvarado-Tapias, Carlos Guarner-Argente, Elida Oblitas, et al.
Journal of Hepatology|June 6, 2022
Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysisCàndid Villanueva, Ferran Torres, Shiv Kumar Sarin, et al.
Hepatology (Baltimore, Md.)|January 19, 2017
A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosisCàndid Villanueva, Isabel Graupera, Carles Aracil, et al.
International Journal of Molecular Sciences|August 10, 2024
Immune Response and Risk of Decompensation following SARS-CoV-2 Infection in Outpatients with Advanced Chronic Liver DiseaseAnna Brujats, Anna Huerta, Rubén Osuna-Gómez, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Scientific Reports|February 1, 2024
Impact of the COVID-19 pandemic on the incidence and type of infections in hospitalized patients with cirrhosis: a retrospective studyBerta Cuyàs, Anna Huerta, Maria Poca, et al.
Gastroenterologia Y Hepatologia|July 1, 2026
Anemia and Hypoalbuminemia are Associated with Hepatic Encephalopathy and Mortality after Portal Hypertension-Related BleedingLaura Bordoy, Anna Brujats, Montserrat Camps, et al.
Obesity Surgery|March 7, 2023
Bariatric Surgery Is Associated with Alcohol-Related Liver Disease and Psychiatric Disorders Associated with AUDEdilmar Alvarado-Tapias, David Marti-Aguado, Kevin Kennedy, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 18, 2024
Influence of further decompensation on survival across clinical stages of decompensated cirrhosis: The role of portal hypertension and HVPG changesMarta Garcia-Guix, Alba Ardevol, Victor Sapena, et al.
Plos One|March 25, 2016
Effects of an Exercise Programme on Functional Capacity, Body Composition and Risk of Falls in Patients with Cirrhosis: A Randomized Clinical TrialEva Román, Cristina García-Galcerán, Teresa Torrades, et al.
European Journal of Public Health|November 10, 2025
Trends in incidence, prevalence, and survival of primary liver cancer in the United Kingdom (2000-2021)Berta Cuyàs, Edilmar Alvarado-Tapias, Eng Hooi Tan, et al.
World Journal of Hepatology|February 6, 2018
Toll-like receptor 4 polymorphisms and bacterial infections in patients with cirrhosis and ascitesEdilmar Alvarado-Tapias, Carlos Guarner-Argente, Elida Oblitas, et al.
Journal of Hepatology|June 6, 2022
Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysisCàndid Villanueva, Ferran Torres, Shiv Kumar Sarin, et al.
Hepatology (Baltimore, Md.)|January 19, 2017
A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosisCàndid Villanueva, Isabel Graupera, Carles Aracil, et al.
International Journal of Molecular Sciences|August 10, 2024
Immune Response and Risk of Decompensation following SARS-CoV-2 Infection in Outpatients with Advanced Chronic Liver DiseaseAnna Brujats, Anna Huerta, Rubén Osuna-Gómez, et al.
Pageof 8